Dr. Peter C. Everett, MD

Dr. Everett practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Everett's NPI, 1144495375, was assigned on April 29, 2008. Dr. Everett graduated from Boston University School of Medicine in 2005. Dr. Everett holds Massachusetts license 252851.

Dr. Everett's primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Everett's primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. The medical group on file is Boston University Medical Group (Boston University Internal Medicine Associates). Dmand AI also links Dr. Everett to 1 more group practice or clinic, named with a free account. Dr. Everett's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Everett practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Everett's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Everett is licensed in Massachusetts.

CMS data shows 290 Medicare services from Dr. Everett across 5 procedure codes in 2024, for 76 Medicare patients. Medicare paid $21,094 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Dr. Everett in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Everett's median patient age at 66, with 49% women.

In 2024, Dr. Everett wrote 445 Medicare Part D claims for 62 patients. 71% of them were for generic drugs. CMS names the drug for 327 of them, across 12 drugs with 11 or more claims each, at $1,042,460 in total drug cost. In 2023, CMS named 453 claims across 16 drugs.

Dr. Everett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Everett as offering telehealth.

Dmand AI links 9 papers to Dr. Everett, published from 2012 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Head and Neck Neoplasms, Immune Checkpoint Inhibitors and Lung Neoplasms. Dr. Everett's most frequent co-authors are Umit Tapan, MD, Michael A. Dyer, MD and Minh Tam Truong, MD.

Dmand AI links Dr. Everett to 6 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Small Cell Lung Carcinoma. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 6 general payments to Dr. Everett from 1 drug or device company in 2023. Travel and lodging make up the largest share, 88% of the total. Merck Sharp & Dohme Corporation paid the most, $997.

Dr. Everett graduated from Boston University School of Medicine in 2005.